Target intelligence / Profile preview

Joint lubrication

Molecular classification
Other
01

Overview

"Joint lubrication" is not a molecule, receptor, enzyme, transporter, or other discrete molecular target. Instead, it refers to the physiological process by which synovial joints are kept moist and slippery, allowing for smooth movement and minimizing friction between articulating surfaces. This process relies on several components within the synovial fluid—primarily hyaluronic acid, lubricin (also known as proteoglycan 4), surface-active phospholipids, and water—which together form various types of lubricant films over cartilage surfaces. The main mechanisms include boundary lubrication (thin molecular layers), fluid film/hydrodynamic lubrication (fluid layers separating surfaces), weeping/squeeze film/boosted/electrohydrodynamic effects depending on load conditions. Disruption or deficiency in these processes contributes significantly to diseases like osteoarthritis due to increased friction and subsequent cartilage damage. While therapies may aim at restoring aspects of this system—such as injecting hyaluronic acid or recombinant lubricin—the term "joint lubrication" itself does not denote a single druggable target but rather an emergent property resulting from multiple interacting molecules. Joint lubrication is best understood as a physiological function rather than a specific molecular entity suitable for direct pharmacological targeting.

Other names
Joint lubricationLubrication of synovial jointsArticular joint lubrication
02

Mechanism of action

Not applicable for "joint lubrication" itself; for related therapies, mechanisms include restoration of boundary or fluid film lubrication by supplementing hyaluronic acid or lubricin

03

Biological functions

Reduction of friction in synovial jointsFacilitation of smooth and efficient joint movementProtection of articular cartilage from wear and damage
04

Disease associations

Osteoarthritis (failure or alteration in joint lubrication is implicated)Inflammatory arthritis (altered lubricant composition can contribute to disease)
05

Safety considerations

Not applicable to the process itself; safety concerns relate to therapeutic interventions (e.g., infection risk with intra-articular injections)
06

Biomarkers

Synovial fluid viscosityLubricin levels in synovial fluidHyaluronic acid concentration

Beyond the preview

Go deeper on Joint lubrication.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joint lubrication.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call